Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with 99mTc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice-Reference-Cited by-同舟云学术

Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with 99mTc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice

Published:2016-05 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhang Deliang,Guo Zhide,Zhang Pu,Li Yesen,Su Xinhui,You Linyi,Gao Mengna,Liu Chang,Wu Hua,Zhang Xianzhong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep25377.pdf

Reference44 articles.

1. Iredale, J. P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539–548 (2007).

2. Albanis, E. & Friedman, S. L. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 5, 315–334 (2001).

3. Kaibori, M. et al. HA/GSA-Rmax ratio as a predictor of postoperative liver failure. World J Surg 32, 2410–2418 (2008).

4. Farges, O. et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229, 210–215 (1999).

5. Manning, D. S. & Afdhal, N. H. Diagnosis and quantitation of fibrosis. Gastroenterology 134, 1670–1681 (2008).

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future;VIEW;2024-07-15

2. In vivo evaluation of liver function by multimodal imaging in an alcohol-induced liver injury model;Quantitative Imaging in Medicine and Surgery;2023-10

3. Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model;Biomaterials Science;2023

4. Nanotechnology in Drug Delivery for Liver Fibrosis;Frontiers in Molecular Biosciences;2022-01-11

5. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis;Advanced Drug Delivery Reviews;2021-09